Brief: Nova Mentis Life Science Corp Says Added Two Additional Psychedelic Compounds To Its Drug Portfolio

Restart Life Sciences

29/12/2020 13:12

Dec 29 (Reuters) - Nova Mentis Life Science Corp  NOVA.CD :
    * NOVA MENTIS LIFE SCIENCE CORP - CO SAYS HAS ADDED TWO
ADDITIONAL
PSYCHEDELIC COMPOUNDS TO ITS DRUG PORTFOLIO
    * NOVA MENTIS - AS PER AGREEMENTS, CO HAS OWNERSHIP OF API
DMF
WHICH WILL BE USED FOR REGULATORY SUBMISSION PRIOR TO COMMENCING
HUMAN CLINICAL TRIALS
    * NOVA MENTIS - CO HAS CONTRACTED WITH ITS U.S. PARTNER TO
BEGIN
MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS, BAEOCYSTIN AND
AERUGINASCIN

Source text for Eikon:  ID:nCNWfH0x8a 
Further company coverage:  NOVA.CD 

 ((Reuters.Briefs@thomsonreuters.com;))